# A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

> **NCT00037674** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 434 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Topiramate

## Key facts

- **NCT ID:** NCT00037674
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** 2003-05
- **Target enrollment:** 434 (ACTUAL)
- **Last updated:** 2011-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00037674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00037674, "A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00037674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*